1 / 11

Process of FDA New Drug Approval: 1- New Compound with promising preclinical data 2- Sponsor applies to FDA for an IND (

Process of FDA New Drug Approval: 1- New Compound with promising preclinical data 2- Sponsor applies to FDA for an IND (Investigational New Drug Application) 3-Sponsor recruits Clinical Investigator 4-Sponsor and Investigator design Clinical Trial 5-Clinical Trial reviewed by IRB

Sophia
Download Presentation

Process of FDA New Drug Approval: 1- New Compound with promising preclinical data 2- Sponsor applies to FDA for an IND (

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Process of FDA New Drug Approval: 1- New Compound with promising preclinical data 2- Sponsorapplies to FDA for an IND (Investigational New Drug Application) 3-Sponsor recruits Clinical Investigator 4-Sponsor and Investigator design Clinical Trial 5-Clinical Trial reviewed by IRB 6-Inf IND and IRB review OK: Clinical Trial 7-Investigator informs IRB and Sponsor 8-Sponsor informs FDA 9-If everything goes smooth after Phase III 10-Sponsor files New Drug Application (NDA) 11-Review of an NDA 12-MARKETING APPROVAL; $$$$ OR LAWSUITS

  2. Internal Review Board (IRB): Peer review for approvaland monitoring of clinical trials submitted by Clinical Investigators (PI) based on: ETHICAL PRINCIPLES: -Respect : Informed consent -Beneficence: Benefits > Risks -Justice: Proper selection of subjects SCIENCE: Trials will allow to asses safety And effectiveness.

  3. IRB Clinical Trials FDA CBER/ CDER Investigator IND NDA Marketing Sponsor

More Related